Laboratory
Product Documents
Scientific Posters
ASM 2008 - Rapid Identification of S. aureus and Coagulase Negative Staphylococci (CNS) Followed by Differentiation Between MRSA and MSSA from Blood Culture Bottles Using S. aureus/CNS PNA FISH(TM) and mecA EVIGENE(TM)
PNA FISH testing followed by mecA EVIGENE(TM) as a rapid algorithm for direct identification of MRSA and MSSA from positive...
KT102-16 and KT102-96 - mecA EVIGENE
EU: For in vitro diagnostic use (CE-IVD).
US: For research use only. Not for use in diagnostic procedures.
mecA EVIGENE provides rapid and accurate detection of the mecA gene from isolates of S. aureus and coagulase-negative staphylococci.
Available in 16 or 96 tests formats.
Features and Benefits
mecA EVIGENE, 16 tests (Cat. No. KT102-16) *New*
mecA EVIGENE, 96 tests (Cat. No. KT102-96)
MRSA – Methicillin-Resistant S. aureus
In the United States more than 60% of S. aureus isolates are now methicillin-resistant, resulting in significant costs to the healthcare system and greater use of vancomycin at the first hint of infection with a Gram-positive cocci.(1,2)
Effective programs to control the spread of MRSA include rapid identification methods as part of active surveillance programs, aggressive intervention once MRSA is identified, as well as an active antibiotic utilization program.(3)
1 NNIS System. http://www.cdc.gov/ncidod/dhqp/pdf/ar/ICU_RESTrend1995-2004.pdf
2 Shah et al. Curr Med Res Opin. 2004 Jun;20(6):779-90.
3 Bootsma et al. Proc Natl Acad Sci U S A. 2006 Mar 24